Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
—
—
—
—
—
—
1 Year
Score—
Net Growth—
Net Trend—
Net Income Consistency—
Rev Growth—
Rev Trend—
Revenue Consistency—
5 Years
—
—
50%
—
—
25%
—
5 Years
Score—
Net Growth—
Net Trend50%
Net Income Consistency—
Rev Growth—
Rev Trend25%
Revenue Consistency—
Kazia Therapeutics Ltd ADR fundamental performance
Across Kazia Therapeutics Ltd ADR's full reported history, from 1999 to 2025, revenue declined from $ 19M to $ 42K and net income went from -$ 17M to -$ 20M. Revenue increased in 42% of the years measured; net income in 54%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 12.79 | — |
1 Year2025-08-12 | $ 8.50 | 50.47% |
5 Years2021-08-12 | $ 444.50 | -97.12% |
10 Years2016-08-12 | $ 394.00 | -96.75% |
20 Years2006-08-11 | $ 3.42K | -99.63% |
All Time1999-01-06 | $ 2.61K | -99.51% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time1999-01-06 |
|---|---|---|---|---|---|---|
| Price | $ 12.79 | $ 8.50 | $ 444.50 | $ 394.00 | $ 3.42K | $ 2.61K |
| Return | — | 50.47% | -97.12% | -96.75% | -99.63% | -99.51% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 69M | ||
| 2025 | $ 42K | -$ 20M | $ 4M |
| 2024 | $ 2M | -$ 26M | $ 1M |
| 2023 | $ 555.00 | -$ 20M | $ 5M |
| 2022 | $ 10K | -$ 25M | $ 7M |
| 2021 | $ 15M | -$ 8M | $ 27M |
| 2020 | $ 988.11K | -$ 12M | $ 8M |
| 2019 | $ 1.56K | -$ 10M | $ 5M |
| 2018 | $ 13.11K | -$ 6M | $ 5M |
| 2017 | $ 8M | -$ 10M | $ 14M |
| 2016 | $ 4M | -$ 12M | $ 33M |
| 2015 | $ 89K | -$ 7M | $ 44M |
| 2014 | $ 87K | -$ 7M | $ 2M |
| 2013 | $ 1M | -$ 1M | $ 8M |
| 2012 | $ 1M | $ 1M | $ 8M |
| 2011 | $ 2M | -$ 6M | $ 6M |
| 2010 | $ 9M | -$ 12M | $ 15M |
| 2009 | $ 11M | -$ 18M | $ 33M |
| 2008 | $ 13M | -$ 20M | $ 34M |
| 2007 | $ 17M | -$ 20M | $ 39M |
| 2006 | $ 13M | -$ 16M | $ 33M |
| 2005 | $ 17M | -$ 12M | $ 47M |
| 2004 | $ 16M | -$ 12M | $ 58M |
| 2003 | $ 32M | -$ 10M | $ 30M |
| 2002 | $ 19M | -$ 14M | $ 39M |
| 2001 | $ 58M | -$ 42M | $ 61M |
| 2000 | $ 26M | -$ 13M | $ 28M |
| IPO1999 | $ 19M | -$ 17M | $ 29M |
Explore beyond KZIA
You're looking at Kazia Therapeutics Ltd ADR. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
